Letters to Otsuka, Janssen Pharmaceutical Companies of Johnson & Johnson, Food and Drug Administration and European Medicines Agency on Delamanid and Bedaquiline and Replies 24 May 2012 21 May 2012 Letter to Otsuka 24 May 2012 Letter to Janssen Pharmaceutical Companies of J&J 24 May 2012 Letter to Food and Drug Administration 24 May 2012 Letter to European Medicines Agency Janssen Response, 12 June 2012 Otsuka Response, 15 June 2012 EMA Response, 7 July 2012
